This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic.
Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.
According to Reuters , Kenya, Tanzania, Senegal and Cameroon have either run out of or are close to running out of vaccines to protect children against the deadly rotavirus infection following undisclosed “manufacturing challenges” at GSK.
The most effective preventive measure against the flu is getting an annual flu vaccine. Getting Vaccinated for the Flu The CDC says ideally, everyone who is eligible for a flu vaccine should be vaccinated by the end of October – the ideal time to get vaccinated being September or October.
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Trend #1: Media and Tech: Facilitating Communication. For example, people mistrust the efficiency and safety of the COVID-19 vaccine. Trend #3: Relationships Despite Digital Congestion.
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
trillion by end of 2020. As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. This already significant industry is growing – it is estimated to be worth $1.27
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.
As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.
As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.
Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.
In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. billion in Covid-19 vaccine sales.
They showed how repetitive patterns of DNA are copied during replication, and found evidence they can stall the process entirely, increasing the risk of errors that can be an early driver of cancer, according to a paper published in the journal Nature Communications. The company signed a collaboration with Boehringer Ingelheim worth up to $1.07
It currently appears highly unlikely that the majority of conferences will simply return to typical face-to-face only formats as they were before 2020. This article summarises the most important lessons learnt during 2020 – 2021. Lessons learnt 2020-2021. yes, if vaccines are available; 15.8% yes; and 15.7%
Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. An analysis performed at the end of 2019 concluded that demand for viral vectors would have surpassed CDMO capacity during 2020.
In 2020, the pharmaceutical supply chain faced one of its biggest global challenges. To develop a vaccine and then get as many people vaccinated as quickly as possible. Advanced monitoring and analysis technology has enabled more than 13 billion COVID-19 vaccinations to be distributed worldwide to date.
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). He holds degree in Electronics and Communications Engineering. and consulting roles.
Digital health firm Livi is planning to step up its digital campaign to encourage people to get their COVID-19 vaccines in the UK, with messaging designed to provide accurate information to patients and counter social media messages from anti-vaxxer groups.
The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. And at the tail end of 2020, a $6.5 Litigation & controversy.
Source: CRA market research (conducted June 2020). More than 100,000 MS patients were included in the data set, defined as patients with two or more MS-related medical claims or one or more MS-related medical claims plus a related pharmacy claim identified between January 2019 and June 2020. Changes in Prescribing by Specialty.
COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . We published our hypothesis in the Lancet on February 4 in 2020.
Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.
A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceutical companies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.
Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. The storage and transportation of temperature-sensitive pharmaceutical products, such as vaccines and biologics, require strict temperature control throughout the supply chain to maintain their efficacy.
Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. How to improve payer engagement with tailored value communication.
Build a base in the community. According to the FDA’s 2020 Drug Trials Snapshot Report , only 8% of clinical trial participants are Black or African American, as compared to nearly 14% of the US population. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate.
Independent communications agency OVID Health has appointed Niall Dickson, professor David Salisbury and Athena Lamnisos as senior counsel, providing strategic advice and thought leadership across several projects involving healthcare and pharma clients. In addition to these appointments, Grace Holland has joined the team as account manager.
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. The European Commission’s Pharmaceutical Strategy for Europe , adopted in November 2020, outlines a series of concrete actions to ensure accessibility, availability, and affordability of medicines.
Data from Ofcom in 2020 found that just under one in five over-75s use a smartphone. As the vaccine roll-out continues, and GPs find more of a rhythm to their everyday appointments again, it’s time to reassess what is, and isn’t important when it comes to providing digital healthcare in the long-term. Be transparent.
Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view. Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has allowed the UK to respond swiftly to the pandemic.
Rewind to March of 2020, and pharma companies were facing a communication crisis. Other uses include providing a platform for key opinion leaders (KOLs), as well as internal communications to make sure that messages are unified across an organisation. The crisis that changed everything.
If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. So as the focus shifts from cost to value, we are now seeing cloud as a CEO agenda item.
Marjo Loisa, the director of communications at THL, told the newspaper that “90% of tweets related to the coronavirus are highly inappropriate, and people are joining other discussions with disinformation as well.” Since its inception in March 2020, 11.72
Regarding OWS’s support for vaccine development, Dr Slaoui noted that 5 of the 6 vaccines selected (from a total of 94 programs) are currently in phase 3 development or approved. The response to this crisis has “transformed the vaccine industry.”.
She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. “When we come together like this, innovation can happen a lot faster.”. Connect with Dr Tunnah at [link] or [link].
With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pandemic, eagerly learning about everything from symptoms to vaccine development. Long-term partners. based site management organization.
Cooke, who has over 30 years of experience in international regulatory affairs, with 18 years in leadership roles, took the helm at EMA as director in November 2020, early in the pandemic, after having worked at EMA since 2002, serving as head of inspections initially and then as head of international affairs from 2009 to 2016.
Okudaira of PMDA agreed that communications may be a driving force of acceptance of new models, and also establishing international convergence documents may help. A 2020 pilot invited external authorities to participate and observe EMA procedures authorizing COVID-19 vaccines and therapeutics. Communication is the key piece.”.
Understanding how to modify communication style is a first step. At the time of this writing, the US death toll is expected to reach 295,000 by December 2020. 1 The first vaccine candidates are progressing towards early to mid-2021 approval. Coupling this with a fluid use of digital assets will set top representatives apart.
In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. This is likely something we will be living with until we crack the code on how to vaccinate the unvaccinated, and even then we’re all likely to be getting boosters for a long-time. In this article, R.J. Innovation & Experimentation.
In fact, more than 95% of Americans live within just a few miles of a community pharmacy, which is one reason why pharmacies will be on the frontlines of administering the COVID-19 vaccine once it’s available.
While the UK fully left the EU in January 2020, Britain was to take part in the Horizon Europe scheme as an associated country. Similarly to its predecessor , Horizon 2020, Horizon Europe is the EU’s research and innovation funding program, with a €95.5 billion ($103 billion) budget. Please check your email to download the Report.
Also, DCT-related home health and/or televisits are coordinated and followed on these platforms while allowing site teams to maintain ongoing communication with patients to provide visit reminders and other contact, which enhances retention every step of the way. are collected and housed together for study team monitoring and oversight.
With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. 2020 Oct 16;9(1):219-228. Hemophilia News Today.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content